Investigators
Study information
- Research Area: COVID-19
- Research type: Prospective
- Start date: May 02, 2020
- End date: May 02, 2022
Study aim of the objectives
Aim: to evaluate the clinical characteristics of the SARS-CoV-2 reactivation in Rwanda. Specific objectives: To determine the clinical features of SARS-CoV-2 r recovered and reactivated patients in Rwanda; To identify the potential risk factors of SARS-CoV-2 reactivation in Rwanda
Study setting/Area (Location)
All COVID-19 treatment sites in Rwanda
Implementing institution
Rwanda Biomedical Center, University of Rwanda and Referral hospitals
Department/Division
Research, Innovation and Data Science, National Reference, Center for Human genetics, CHUK and Kacyiru Hospital
Impact on Policy
The findings will inform treatment guidelines of COVID-19